ARTICLE | Company News
Advanced Biotherapy, Innogenetics NV deal
May 10, 2004 7:00 AM UTC
INNX and ADVB cross-licensed their respective interferon gamma IP related to various autoimmune diseases. The deal initially will cover applications in rheumatoid arthritis (RA), with an option to inc...